K-numberK250322
Device nameRespond OC Conserving Regulator (130-0800)
ApplicantResponsive Respiratory
Product codeNFB
Device classClass II
Decision dateJul 24, 2025
DecisionSubstantially Equivalent
Regulation868.5905
AI Summary extracted from FDA summary PDF · never regenerated
Intended use

The Respond OC Conserving Regulator is a dual-mode oxygen delivery device designed for patients requiring supplemental oxygen at home or during travel. It delivers oxygen either as a continuous flow (2-4 LPM) or in short bursts triggered by the patient's inhalation (1-5 LPM equivalent conserve mode), extending cylinder duration up to 6:1 compared to continuous flow alone.

Technological characteristics

The device is a pneumatic (non-electric) regulator with a CGA 870 yoke for high-pressure cylinders (300-3000 psig inlet), a sensing diaphragm that detects inhalation, and a click-style flow control knob. It delivers oxygen boluses in the early inhalation phase, has a nominal outlet pressure of 22 PSI, and uses a standard single-lumen nasal cannula up to 7 feet long.

Test standards cited

ISO 18562-2 (particulate matter emissions), ISO 18562-3 (VOC emissions with toxicological risk assessment), and ASTM G 175-24 (ignition sensitivity and fault tolerance). Performance testing included accelerated aging, flow comparison, flow regulation, conservation testing, burst pressure, environmental and altitude testing, flow response, and impact testing.

Substantial equivalence argument

Both the subject device and predicate (Chad Therapeutics Bonsai Model 800) are pneumatic combination regulators with identical indications for use, patient populations, environments, and operating principles—both sense inhalation and deliver pulsed oxygen via nasal cannula with 6:1 conservation ratios. The minor functional difference in bolus delivery timing (subject delivers in first 1/3 versus predicate's first 1/2 of inhalation cycle) represents less than 0.4-second variation across breathing rates (15-30 BPM) and does not raise different safety or effectiveness questions. Bench testing confirms the subject device performs similarly to the predicate across all comparable parameters.

Extracted by AI from the official FDA summary PDF →
Source

View the full FDA submission: accessdata.fda.gov

Researching this as a predicate?
Want a transparent AI-ranking score, AI-discovered related predicates, ongoing safety and warning-letter monitoring, full predicate chain lineage, and a drafted SE rationale — all saved to your own project? That's what an account adds.
Start free trial →

Everything you need for a 510(k) submission. Nothing you don't.

14-day free trial. No setup. Cancel anytime.

Start free trial →
Building an AI or ML-enabled device? Predicate search, PCCP tracking, and AI-specific FDA intelligence — built exclusively for AI/ML devices. Try AIFDA Intel →